Year archive

IRLAB Therapeutics — 2021 filings

All 23 regulatory filings released by IRLAB Therapeutics (IRLAB) in 2021, sourced directly from the official regulator.

23 Filings

2021 Period

2021 filings (23)

Filing	Released	Lang
Board member leaves IRLAB for another assignment Board/Management Information	2021-12-31	English
Styrelseledamot lämnar IRLAB:s styrelse för nytt uppdrag Board/Management Information	2021-12-31	Swedish
IRLAB erhåller regulatoriskt godkännande att genomföra Fas IIb studie med pirepemat - ett steg närmare möjligheten att förbättra balans och minska fallskador för patienter med Parkinson Regulatory Filings	2021-12-21	Swedish
IRLAB obtains regulatory approval to conduct Phase IIb study with pirepemat – one step closer to improving balance and reducing fall injuries for people living with Parkinson’s disease Regulatory Filings	2021-12-21	English
Interim / Quarterly Report 2021 Interim / Quarterly Report 9M 2021	2021-11-10	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report 9M 2021	2021-11-10	English
Nomination committee in IRLAB appointed ahead of annual general meeting 2022 Board/Management Information	2021-11-05	English
Valberedningen utsedd inför IRLABs årsstämma 2022 Board/Management Information	2021-11-05	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report Q2 2021	2021-08-25	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report Q2 2021	2021-08-25	English
Ipsen and IRLAB enter exclusive worldwide licensing agreement aimed to improve the lives of people living with Parkinson’s disease Regulatory Filings	2021-07-15	English
Ipsen och IRLAB ingår exklusivt globalt licensavtal som syftar till att förbättra livet för personer med Parkinsons sjukdom Capital/Financing Update	2021-07-15	Swedish
Kommuniké från årsstämma 2021 AGM Information	2021-05-06	Swedish
Report from the annual general meeting of IRLAB Therapeutics AB AGM Information	2021-05-06	English
Interim / Quarterly Report 2021 Interim / Quarterly Report Q1 2021	2021-05-06	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report Q1 2021	2021-05-06	English
Annual Report 2020 Annual Report FY 2020	2021-04-15	Swedish
Annual Report 2020 Annual Report FY 2020	2021-04-15	English
IRLAB kallar till årsstämma den 6 maj 2021 AGM Information	2021-04-06	Swedish
Interim / Quarterly Report 2020 Interim / Quarterly Report Q4 2020	2021-02-24	Swedish
Interim / Quarterly Report 2020 Interim / Quarterly Report FY 2020	2021-02-24	English
IRLAB announces change in share capital and number of shares following registered directed share issue Declaration of Voting Results & Voting Rights Announcements	2021-01-29	English
IRLAB meddelar förändring av aktiekapital och antal aktier efter registrerad riktad emission Share Issue/Capital Change	2021-01-29	Swedish